A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma

NCT00000763 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

NIH

Sponsor class

Conditions

Sarcoma, Kaposi
HIV Infections

Interventions

DRUG: TNP-470

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)